Atlas Trials

Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer

Clinical trial NCT04826107 · UNKNOWN

Trial details

NCT number
NCT04826107
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2021-08-01
Primary completion
2024-08-01
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.